Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Mailliard

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Cancer|May 1, 1993
A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment GroupD H Gesme, J R Jett, D D Schreffler, et al.
Cancer|May 15, 1989
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancerR F Marschke, J N Ingle, D J Schaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Phase II trial of irinotecan in patients with metastatic colorectal carcinomaH C Pitot, D B Wender, M J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group resultsE Galanis, J C Buckner, P A Burch, et al.
Cancer|January 5, 2000
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinomaE A Perez, D W Hillman, P J Stella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I studyS R Alberts, P M Townley, R M Goldberg, et al.
Lancet (London, England)|January 6, 2001
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trialC L Loprinzi, J W Kugler, J A Sloan, et al.
Cancer Investigation|August 7, 2001
Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group StudyJ H Edmonson, V J Suman, R J Dalton, et al.
Leukemia|August 2, 2001
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemiaA Tefferi, C Y Li, C B Reeder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II studyS R Alberts, P M Townley, R M Goldberg, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Cancer|May 1, 1993
A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment GroupD H Gesme, J R Jett, D D Schreffler, et al.
Cancer|May 15, 1989
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancerR F Marschke, J N Ingle, D J Schaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Phase II trial of irinotecan in patients with metastatic colorectal carcinomaH C Pitot, D B Wender, M J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group resultsE Galanis, J C Buckner, P A Burch, et al.
Cancer|January 5, 2000
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinomaE A Perez, D W Hillman, P J Stella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I studyS R Alberts, P M Townley, R M Goldberg, et al.
Lancet (London, England)|January 6, 2001
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trialC L Loprinzi, J W Kugler, J A Sloan, et al.
Cancer Investigation|August 7, 2001
Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group StudyJ H Edmonson, V J Suman, R J Dalton, et al.
Leukemia|August 2, 2001
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemiaA Tefferi, C Y Li, C B Reeder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II studyS R Alberts, P M Townley, R M Goldberg, et al.
Pageof 10